News

2015 Nobel Prize for Medicine honors parasitic disease research


 

References

Three biomedical scientists who developed revolutionary therapies for the treatment of parasitic diseases have won the 2015 Nobel Prize in Physiology or Medicine.

Microbiologists William C. Campbell, PhD, and Satoshi Omura, PhD, were honored for the discovery of avermectin, the derivatives of which have radically lowered the incidence of river blindness and lymphatic filariasis, as well as showing efficacy against an expanding number of other parasitic diseases. Dr. Campbell and Dr. Omura shared the award with pharmacologist Youyou Tu, who discovered artemisinin, a drug that has significantly reduced the mortality rates for patients suffering from malaria.

Dr. Campbell, an expert in parasite biology, is based at Drew University in Madison, N.J., while Dr. Omura, renowned for his expertise in isolating natural products, works at Kitasato University in Tokyo. Ms. Tu, the first China-based researcher to win a science Nobel, is chief professor at the China Academy of Traditional Chinese Medical Sciences in Beijing.

According to the prize announcement from the Nobel Assembly at Karolinska Institutet in Stockholm, the research of the 2015 Physiology or Medicine Laureates “represents a paradigm shift in medicine, which has not only provided a revolutionary therapy for patients suffering from devastating parasitic diseases, but it has also promoted well-being and prosperity of both individuals and society. The global impact of their discoveries and the benefit to mankind is immeasurable.”

Read the 2015 Nobel Prize in Physiology or Medicine announcement here, and the complete scientific statement supporting the winners here.

rpizzi@frontlinemedcom.com

On Twitter @richpizzi

Recommended Reading

Delayed treatment associated with higher mortality from VRE bloodstream infections
MDedge Emergency Medicine
Septicemia due to ‘ESKAPE’ pathogens rose between 2008 and 2012
MDedge Emergency Medicine
ICU care improves survival without raising costs
MDedge Emergency Medicine
Reported pertussis underestimates true incidence by up to 93-fold
MDedge Emergency Medicine
Long-term ceftaroline use associated with neutropenia
MDedge Emergency Medicine
HHS funds development of experimental Ebola drug
MDedge Emergency Medicine
Ebola virus in semen raises possibility of sexual transmission
MDedge Emergency Medicine
Feds, drug company team up to combat bioterrorism
MDedge Emergency Medicine
Ocular syphilis on the rise: What clinicians must know
MDedge Emergency Medicine
First EDition: News for and about the practice of emergency medicine
MDedge Emergency Medicine